Semler Scientific Hits New 52-Week Low at $23.51 Amid Declining Performance

Semler Scientific, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 23.51 on October 13, 2025. This decline marks a significant downturn for the company, which has seen its stock price decrease by 27.43% over the past year, contrasting sharply with the S&P 500's performance of 13.36% during the same period. The company's financial metrics reflect ongoing difficulties, with a price-to-earnings ratio of 24.00 and a return on equity of 3.43%. Semler Scientific has not paid dividends, maintaining a yield of 0.00%. Additionally, the company has reported negative results for the last four consecutive quarters, with the most recent quarter showing net sales of only USD 8.22 million and an operating cash flow of USD 12.45 million, both of which are at their lowest levels. With a market capitalization of USD 425 million, Semler Scientific's stock performance continues to be closely monitored as it navigates these challenging financial conditions.